Breaking News

Islet Sciences Selects PCT to Manufacture Cell Therapy

PCT gets exclusive manufacturing rights and royalties on future sales

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Progenitor Cell Therapy (PCT) the cell therapy manufacturing division of NeoStem, entered an agreement to provide contract manufacturing and regulatory services for the development of Islet Sciences’ PTM, an injectable suspension of microencapsulated insulin-producing, pancreatic islet cells harvested from pathogen-free pigs. PCT will perform microencapsulation for pancreatic islets for xenotransplantation using piglet pancreata. Islet Sciences, a biotech company engaged in R&D and commercia...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters